Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Estramustine Phosphate Combined With Taxol in Hormone Refractory Prostate Cancer
NCT00038168Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2000
- Primary completion
- Jan 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of estramustine in prostate cancer (PCa), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Response Rate. Started Jun 2000; status: completed.
02
Drugs
estramustine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00038168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038168.